Standout Papers

EASL Clinical Practice Guidelines: Management of... 2010 2026 2015 2020 6.6k
  1. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma (2018)
    Peter R. Galle, Alejandro Forner et al. Journal of Hepatology
  2. Hepatocellular carcinoma (2018)
    Alejandro Forner, María Reig et al. The Lancet
  3. Hepatocellular carcinoma (2012)
    Alejandro Forner, Josep M. Llovet et al. The Lancet
  4. BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update (2021)
    María Reig, Alejandro Forner et al. Journal of Hepatology
  5. Current Strategy for Staging and Treatment: The BCLC Update and Future Prospects (2010)
    Alejandro Forner, María Reig et al. Seminars in Liver Disease
  6. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma (2007)
    Alejandro Forner, R. Vilana et al. Hepatology
  7. Chemoembolization of hepatocellular carcinoma with drug eluting beads: Efficacy and doxorubicin pharmacokinetics (2006)
    Marı́a Varela, María Isabel Real et al. Journal of Hepatology
  8. Management of HCC (2012)
    Carlos Rodríguez de Lope, Silvia Tremosini et al. Journal of Hepatology
  9. Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: Available evidence and expert opinion on the use of transarterial chemoembolization (2010)
    Jean‐Luc Raoul, Bruno Sangro et al. Cancer Treatment Reviews
  10. Updated use of TACE for hepatocellular carcinoma treatment: How and when to use it based on clinical evidence (2018)
    Jean‐Luc Raoul, Alejandro Forner et al. Cancer Treatment Reviews
  11. Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design (2012)
    Marta Burrel, María Reig et al. Journal of Hepatology
  12. Treatment of intermediate-stage hepatocellular carcinoma (2014)
    Alejandro Forner, Marine Gilabert et al. Nature Reviews Clinical Oncology
  13. EASL-ILCA Clinical Practice Guidelines on the management of intrahepatic cholangiocarcinoma (2023)
    Domenico Alvaro, Gregory J. Gores et al. Journal of Hepatology

Immediate Impact

2 by Nobel laureates 17 from Science/Nature 139 standout
Sub-graph 1 of 15

Citing Papers

Changing etiology and epidemiology of hepatocellular carcinoma: Asia and worldwide
2024 Standout
Natural killer cell therapies
2024 StandoutNature
1 intermediate paper

Works of Alejandro Forner being referenced

Hepatocellular carcinoma
2018 Standout
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout

Author Peers

Author Last Decade Papers Cites
Alejandro Forner 16813 9849 4336 4861 118 24.2k
Morris Sherman 23513 16735 4188 4379 196 30.9k
Riccardo Lencioni 19952 10252 4668 3758 280 27.9k
Laura Kulik 15323 8093 2763 2434 147 19.3k
María Reig 10714 6295 2938 3203 158 15.5k
Myron Schwartz 12616 6754 3824 3155 325 20.3k
Jean‐Luc Raoul 11273 9141 11767 4668 341 25.6k
Lewis R. Roberts 12828 9380 6113 6406 417 28.4k
Bruno Sangro 15541 8005 7306 3400 410 24.8k
Luigi Bolondi 12197 8227 2060 2964 272 18.0k
Vincenzo Mazzaferro 24135 14779 7444 5910 357 36.6k

All Works

Loading papers...

Rankless by CCL
2026